74 related articles for article (PubMed ID: 34019859)
21. The potential mechanism of WT1-associated protein-induced N-6-methyladenosine modification of colony-stimulating factor 2 in the progression of oral squamous cell carcinoma by JAK/STAT3 pathway regulation.
Peng R; Jiang S; Jin Z
Eur J Oral Sci; 2024 Jun; ():e13001. PubMed ID: 38831514
[TBL] [Abstract][Full Text] [Related]
22. Molecular docking analysis of proflavin with the Wnt pathway targets for OSCC.
Pazhani J; Veeraraghavan VP; Jayaraman S
Bioinformation; 2023; 19(4):464-466. PubMed ID: 37822816
[TBL] [Abstract][Full Text] [Related]
23. Expression profiling of signal transducer and activator of transcription3 in oral squamous cell carcinoma in south Indian population.
Thomas P; Selvakumar SC; Preethi KA; Sekar D
Minerva Dent Oral Sci; 2024 Feb; 73(1):37-44. PubMed ID: 37878241
[TBL] [Abstract][Full Text] [Related]
24. Biological significance and therapeutic implication of resveratrol-inhibited Wnt, Notch and STAT3 signaling in cervical cancer cells.
Zhang P; Li H; Yang B; Yang F; Zhang LL; Kong QY; Chen XY; Wu ML; Liu J
Genes Cancer; 2014 May; 5(5-6):154-64. PubMed ID: 25061499
[TBL] [Abstract][Full Text] [Related]
25. Up-regulation of TNF-alpha/NFkB/SIRT1 axis drives aggressiveness and cancer stem cells accumulation in chemoresistant oral squamous cell carcinoma.
de Castro LR; de Oliveira LD; Milan TM; Eskenazi APE; Bighetti-Trevisan RL; de Almeida OGG; Amorim MLM; Squarize CH; Castilho RM; de Almeida LO
J Cell Physiol; 2024 Feb; 239(2):e31164. PubMed ID: 38149816
[TBL] [Abstract][Full Text] [Related]
26. Limonin inhibits the stemness of cancer stem-like cells derived from colorectal carcinoma cells potentially
Zhang WF; Ruan CW; Wu JB; Wu GL; Wang XG; Chen HJ
World J Clin Oncol; 2024 Feb; 15(2):317-328. PubMed ID: 38455137
[TBL] [Abstract][Full Text] [Related]
27. Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK signaling in pancreatic cancer cells.
Ye T; Su J; Huang C; Yu D; Dai S; Huang X; Chen B; Zhou M
Onco Targets Ther; 2016; 9():7481-7492. PubMed ID: 28003763
[TBL] [Abstract][Full Text] [Related]
28. Matrix-based molecular mechanisms, targeting and diagnostics in oral squamous cell carcinoma.
Mastronikolis NS; Kyrodimos E; Piperigkou Z; Spyropoulou D; Delides A; Giotakis E; Alexopoulou M; Bakalis NA; Karamanos NK
IUBMB Life; 2024 Jan; ():. PubMed ID: 38168122
[TBL] [Abstract][Full Text] [Related]
29. Systemic and Local Administration of a Dual-siRNA Complex Efficiently Inhibits Tumor Growth and Bone Invasion in Oral Squamous Cell Carcinoma.
Ma P; He M; Lian H; Li J; Gao Y; Wu J; Men K; Men Y; Li C
Mol Pharm; 2024 Feb; 21(2):661-676. PubMed ID: 38175819
[TBL] [Abstract][Full Text] [Related]
30. Crosstalk between Non-Coding RNAs and Wnt/β-Catenin Signaling in Head and Neck Cancer: Identification of Novel Biomarkers and Therapeutic Agents.
Sajeev A; BharathwajChetty B; Vishwa R; Alqahtani MS; Abbas M; Sethi G; Kunnumakkara AB
Noncoding RNA; 2023 Oct; 9(5):. PubMed ID: 37888209
[TBL] [Abstract][Full Text] [Related]
31. Interplay of p62-mTORC1 and EGFR signaling promotes cisplatin resistance in oral cancer.
Chang HC; Yang CC; Loi LK; Hung CH; Wu CH; Lin YC
Heliyon; 2024 Mar; 10(6):e28406. PubMed ID: 38560690
[TBL] [Abstract][Full Text] [Related]
32. Retraction Note: Downregulation of nicotinamide N-methyltransferase inhibits migration and epithelial-mesenchymal transition of esophageal squamous cell carcinoma via Wnt/β-catenin pathway.
Cui Y; Zhang L; Wang W; Ma S; Liu H; Zang X; Zhang Y; Guan F
Mol Cell Biochem; 2024 Feb; 479(2):451. PubMed ID: 38329637
[No Abstract] [Full Text] [Related]
33. Corrigendum to "MIOX inhibits autophagy to regulate the ROS -driven inhibition of STAT3/c-Myc-mediated epithelial-mesenchymal transition in clear cell renal cell carcinoma" [Redox Biol. 68 (2023) 102956].
Meng L; Gao J; Mo W; Wang B; Shen H; Cao W; Ding M; Diao W; Chen W; Zhang Q; Shu J; Dai H; Guo H
Redox Biol; 2024 Feb; 69():102997. PubMed ID: 38129197
[No Abstract] [Full Text] [Related]
34. Correction to: Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy.
Liu PY; Su CH; Kuo FY; Lee WL; Wang YC; Lin WS; Chu PH; Lu TM; Lo PH; Lee CH; Lan WR; Huang CL; Tsukiyama S; Yang WC; Cheng LC; Rafael V; Nikolajsen C; Yin WH
Cardiovasc Interv Ther; 2022 Apr; 37(2):279-280. PubMed ID: 34021881
[No Abstract] [Full Text] [Related]
35. The intravenous administration of skin-derived mesenchymal stem cells ameliorates hearing loss and preserves cochlear hair cells in cisplatin-injected mice: SMSCs ameliorate hearing loss and preserve outer hair cells in mice.
Tsai SC; Lin FC; Chang KH; Li MC; Chou RH; Huang MY; Chen YC; Kao CY; Cheng CC; Lin HC; Hsu YC
Hear Res; 2022 Jan; 413():108254. PubMed ID: 34020824
[TBL] [Abstract][Full Text] [Related]
36. Developments and future prospects of personalized medicine in head and neck squamous cell carcinoma diagnoses and treatments.
Jayawickrama SM; Ranaweera PM; Pradeep RGGR; Jayasinghe YA; Senevirathna K; Hilmi AJ; Rajapakse RMG; Kanmodi KK; Jayasinghe RD
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2045. PubMed ID: 38522008
[TBL] [Abstract][Full Text] [Related]
37. Chaperonin containing TCP1 subunit 6A may activate Notch and Wnt pathways to facilitate the malignant behaviors and cancer stemness in oral squamous cell carcinoma.
Chen Y; Chen Y; Liu W
Cancer Biol Ther; 2024 Dec; 25(1):2287122. PubMed ID: 38084868
[TBL] [Abstract][Full Text] [Related]
38. Cancer stem cells of head and neck squamous cell carcinoma; distance towards clinical application; a systematic review of literature.
Sun Q; Chen X; Luo H; Meng C; Zhu D
Am J Cancer Res; 2023; 13(9):4315-4345. PubMed ID: 37818051
[TBL] [Abstract][Full Text] [Related]
39. Targeting the Interplay of Autophagy and ROS for Cancer Therapy: An Updated Overview on Phytochemicals.
Dong L; He J; Luo L; Wang K
Pharmaceuticals (Basel); 2023 Jan; 16(1):. PubMed ID: 36678588
[TBL] [Abstract][Full Text] [Related]
40. A Mechanism of Isoorientin-Induced Apoptosis and Migration Inhibition in Gastric Cancer AGS Cells.
Zhang T; Xiu YH; Xue H; Li YN; Cao JL; Hou WS; Liu J; Cui YH; Xu T; Wang Y; Jin CH
Pharmaceuticals (Basel); 2022 Dec; 15(12):. PubMed ID: 36558992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
